These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8943142)

  • 21. Perceptual-acoustic relationships in spasmodic dysphonia.
    Zwirner P; Murry T; Woodson GE
    J Voice; 1993 Jun; 7(2):165-71. PubMed ID: 8353631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of dysfunction of the voice (author's transl)].
    Schultz-Coulon HJ
    Arch Otorhinolaryngol; 1980; 227(1-2):1-169. PubMed ID: 7469924
    [No Abstract]   [Full Text] [Related]  

  • 23. Stiffness of the vocal cord in dysphonia-its assessment and treatment.
    Isshiki N; Ohkawa M; Goto M
    Acta Otolaryngol Suppl; 1984; 419():167-74. PubMed ID: 6599227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A generalized procedure for analyzing sustained and dynamic vocal fold vibrations from laryngeal high-speed videos using phonovibrograms.
    Unger J; Schuster M; Hecker DJ; Schick B; Lohscheller J
    Artif Intell Med; 2016 Jan; 66():15-28. PubMed ID: 26597002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vocal fatigue: current knowledge and future directions.
    Welham NV; Maclagan MA
    J Voice; 2003 Mar; 17(1):21-30. PubMed ID: 12705816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic MRI of larynx and vocal fold vibrations in normal phonation.
    Ahmad M; Dargaud J; Morin A; Cotton F
    J Voice; 2009 Mar; 23(2):235-9. PubMed ID: 18082366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report in changes in phonatory physiology following voice therapy: application of high-speed imaging.
    Patel RR; Pickering J; Stemple J; Donohue KD
    J Voice; 2012 Nov; 26(6):734-41. PubMed ID: 22717492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Exact Analytical Model for the Relationship Between Flow Resistance and Geometric Properties of Tubes Used in Semi-occluded Vocal Tract Exercises.
    da Silva AR; Ghirardi AC; Reiser MR; Paul S
    J Voice; 2019 Sep; 33(5):585-590. PubMed ID: 29861290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking change in dysphonia: a case study.
    Schneider P
    J Voice; 1993 Jun; 7(2):179-88. PubMed ID: 8353633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia.
    Zwirner P; Murry T; Woodson GE
    Eur Arch Otorhinolaryngol; 1997; 254(8):391-5. PubMed ID: 9332896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of voice therapy from patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal fold lesions.
    Ziegler A; Dastolfo C; Hersan R; Rosen CA; Gartner-Schmidt J
    J Voice; 2014 Nov; 28(6):742-52. PubMed ID: 24841669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meaningful features of voice range profiles from patients with organic vocal fold pathology: a preliminary study.
    Behrman A; Agresti CJ; Blumstein E; Sharma G
    J Voice; 1996 Sep; 10(3):269-83. PubMed ID: 8865098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of vocal abuse: fluctuations in phonation time and intensity in 4 groups of speakers.
    Masuda T; Ikeda Y; Manako H; Komiyama S
    Acta Otolaryngol; 1993 Jul; 113(4):547-52. PubMed ID: 8379311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perceptual method and videostroboscopy in patients with vocal fold hypertrophy underwent microsurgery].
    Fira R; Orecka B; Namysłowski G; Misiołek M; Scierski W
    Otolaryngol Pol; 2006; 60(4):529-35. PubMed ID: 17152805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speech task effects on acoustic and aerodynamic measures of women with vocal nodules.
    Sapienza CM; Stathopoulos ET
    J Voice; 1995 Dec; 9(4):413-8. PubMed ID: 8574307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supraglottic activity: evidence of vocal hyperfunction or laryngeal articulation?
    Stager SV; Bielamowicz SA; Regnell JR; Gupta A; Barkmeier JM
    J Speech Lang Hear Res; 2000 Feb; 43(1):229-38. PubMed ID: 10668665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.